Your browser doesn't support javascript.
loading
Adverse events of systemic immune-based combination therapies in the first-line treatment of patients with metastatic renal cell carcinoma: systematic review and network meta-analysis.
Quhal, Fahad; Mori, Keiichiro; Remzi, Mesut; Fajkovic, Harun; Shariat, Shahrokh F; Schmidinger, Manuela.
Afiliação
  • Quhal F; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Mori K; Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
  • Remzi M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Fajkovic H; Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
  • Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Schmidinger M; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.
Curr Opin Urol ; 31(4): 332-339, 2021 07 01.
Article em En | MEDLINE | ID: mdl-33965978
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria